SUMMARY Biopsied tumour cells from astrocytoma-bearing patients were grown in primary culture for 3-5 days. Both low and high grade tumours were represented in the study. The cultured cells could be shown to express the HLA-A and -B antigens using a multispecific allo-antiserum and a rabbit anti-f-2 microglobulin antibody. The tumour cells were negative for the HLA-DR determinants when tested with either rabbit anti-Ia-like antisera or specific anti-HLA-DR allo-antisera. They also failed to stimulate allogeneic lymphocytes in primary mixed lymphocyte-tumour cell cultures but stimulated lymphocytes primed to tumour cells in vitro. The tumour cells were also capable of stimulating autologous lymphocytes from the tumour-bearing patient in most of the combinations tested. 
The expression of histocompatibility antigens (HLA) on malignant cells is of importance for a variety of reasons. These include the demonstration of alterations in the expression of histocompatibility antigens by cells which have undergone malignant transformation;' the increased susceptibility to particular malignant diseases in association with certain HLA antigens2 and the importance of matching for histocompatibility antigens between T cytotoxic cells and transformed target cells in certain experimental situations.3 4 Tumours of the central nervous system are unique in that they arise in an area considered immunologically privileged5 and that they very seldom metastatise. The presence of gliomaassociated antigens has been suggested by various investigators6 7 and both cellular and hormonal responses have been demonstrated in patients with malignant gliomas8-11 although many of the reported studies are still controversial.
We have studied the expression of the HLA-A, -B, -D and -DR antigens on astrocytoma cells in short term cultures. Our results indicate that although astrocytoma cells carry HLA-A and -B antigens, they do not react with anti HLA-DR allo-antisera or anti-Ia-like xenoantisera. Although the tumour cells were capable of stimulating autologous lymphocytes from the tumour-bearing patient, they did not stimulate allogeneic cells from healthy donors.
Materials and methods
Patients Twenty-two patients with various grades of astrocytomas (I-IV) were used in this study. The grading system described in the Kernohan classification has been used throughout this paper.12 13 Priming of allogeneic lymphocytes to tumour antigens 5 x 106 PBM were co-cultured with 2 5 x 106 irradiated tumour cells in 10 ml of culture medium containing 10% human inactivated serum and antibiotics for 12 days in upright T-25 flasks. After this priming incubation, the cells were reseparated on Ficoll-Isopaque to remove dead cells and washed twice. 5 x 104 primed cells were co-cultured with an equal amount of irradiated tumour cells, which had been stored in liquid nitrogen and thawed 24 hrs before used. The secondary cultures were incubated for 5 days, labelled and harvested as previously described.
Results

TUMOUR CELL CULTURES
Twenty-two biopsied tumours were available for culturing. Four biopsies were grades I-IT, eight grades III-IV (glioblastoma multiforme) and the remaining four as "not certain". Of 18 cultures started, 14 
